159 related articles for article (PubMed ID: 16416745)
21. [Study on factor VIII complex in 106 cases of liver disease (author's transl)].
Aihara M; Sawada Y; Kimura A; Chiba Y; Yoshida Y
Rinsho Ketsueki; 1980 Nov; 21(11):1655-63. PubMed ID: 6782276
[No Abstract] [Full Text] [Related]
22. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
23. [Plasma levels of von Willebrand factor in patients under integrated surgical-chemical therapy for ovarian cancer].
Facchini V; Gadducci A; Del Bravo B; Baicchi U; Manfredini C; Lelli L; Fioretti P
Minerva Ginecol; 1988 Apr; 40(4):231-4. PubMed ID: 3140075
[No Abstract] [Full Text] [Related]
24. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand Factor.
Coca M; Cucuianu M; Hâncu N
Rom J Intern Med; 2005; 43(1-2):115-26. PubMed ID: 16739871
[TBL] [Abstract][Full Text] [Related]
25. Von Willebrand factor does not vary during normal menstrual cycle.
Onundarson PT; Gudmundsdottir BR; Arnfinnsdottir AV; Kjeld M; Olafsson O
Thromb Haemost; 2001 Jan; 85(1):183-4. PubMed ID: 11204575
[No Abstract] [Full Text] [Related]
26. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
Yoshioka A
Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
[No Abstract] [Full Text] [Related]
27. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
28. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
Castaman G; Giacomelli S; Rodeghiero F
Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
[TBL] [Abstract][Full Text] [Related]
29. A new automated screening assay for the diagnosis of von Willebrand disease.
Salem RO; Van Cott EM
Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
[TBL] [Abstract][Full Text] [Related]
30. In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates.
Tagariello G; Zanotto D; Radossi P; Sartori R; Belvini D; Salviato R
Am J Hematol; 2007 Jun; 82(6):460-2. PubMed ID: 17211843
[TBL] [Abstract][Full Text] [Related]
31. von Willebrand factor content in Alphanate.
Logan LJ
Haemophilia; 2009 Jan; 15(1):369; author reply 370-1. PubMed ID: 18717740
[No Abstract] [Full Text] [Related]
32. ADAMTS-13 content of plasma-derived factor VIII/ von Willebrand factor concentrates.
Kingsland S; Feldman P
Am J Hematol; 2014 Jun; 89(6):667-8. PubMed ID: 24615674
[No Abstract] [Full Text] [Related]
33. Assessing bleeding in von Willebrand disease with bleeding score.
Tosetto A; Castaman G; Rodeghiero F
Blood Rev; 2007 Mar; 21(2):89-97. PubMed ID: 16774804
[TBL] [Abstract][Full Text] [Related]
34. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
Budde U; Pieconka A; Will K; Schneppenheim R
Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
[TBL] [Abstract][Full Text] [Related]
35. Cryoprecipitated factor VIII concentrate.
Pool JG
Thromb Diath Haemorrh Suppl; 1968; 35():35-40. PubMed ID: 5317363
[No Abstract] [Full Text] [Related]
36. Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease.
Rivard GE; Aledort L;
Haemophilia; 2008 Mar; 14(2):271-5. PubMed ID: 18194310
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.
Soundar EP; Reyes M; Korte L; Bracey A
Blood Transfus; 2018 Sep; 16(5):443-446. PubMed ID: 29106354
[TBL] [Abstract][Full Text] [Related]
38. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
Jacquemin M
Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
[TBL] [Abstract][Full Text] [Related]
39. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
[TBL] [Abstract][Full Text] [Related]
40. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
